346 related articles for article (PubMed ID: 22050408)
1. Ultrastable, redispersible, small, and highly organomodified mesoporous silica nanotherapeutics.
Lin YS; Abadeer N; Hurley KR; Haynes CL
J Am Chem Soc; 2011 Dec; 133(50):20444-57. PubMed ID: 22050408
[TBL] [Abstract][Full Text] [Related]
2. Using shell-tunable mesoporous Fe3O4@HMS and magnetic separation to remove DDT from aqueous media.
Tian H; Li J; Shen Q; Wang H; Hao Z; Zou L; Hu Q
J Hazard Mater; 2009 Nov; 171(1-3):459-64. PubMed ID: 19586720
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
[TBL] [Abstract][Full Text] [Related]
4. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery.
Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J
ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402
[TBL] [Abstract][Full Text] [Related]
5. Adsorption and release of biocides with mesoporous silica nanoparticles.
Popat A; Liu J; Hu Q; Kennedy M; Peters B; Lu GQ; Qiao SZ
Nanoscale; 2012 Feb; 4(3):970-5. PubMed ID: 22200056
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption.
Huang S; Li C; Cheng Z; Fan Y; Yang P; Zhang C; Yang K; Lin J
J Colloid Interface Sci; 2012 Jun; 376(1):312-21. PubMed ID: 22444483
[TBL] [Abstract][Full Text] [Related]
7. Stability of small mesoporous silica nanoparticles in biological media.
Lin YS; Abadeer N; Haynes CL
Chem Commun (Camb); 2011 Jan; 47(1):532-4. PubMed ID: 21082109
[TBL] [Abstract][Full Text] [Related]
8. Effective controlled release of captopril by silylation of mesoporous MCM-41.
Qu F; Zhu G; Huang S; Li S; Qiu S
Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
[TBL] [Abstract][Full Text] [Related]
9. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobic core/hydrophilic shell structured mesoporous silica nanospheres: enhanced adsorption of organic compounds from water.
Li S; Jiao X; Yang H
Langmuir; 2013 Jan; 29(4):1228-37. PubMed ID: 23293877
[TBL] [Abstract][Full Text] [Related]
12. Molecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material.
Mellaerts R; Roeffaers MB; Houthoofd K; Van Speybroeck M; De Cremer G; Jammaer JA; Van den Mooter G; Augustijns P; Hofkens J; Martens JA
Phys Chem Chem Phys; 2011 Feb; 13(7):2706-13. PubMed ID: 21152589
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of biocompatible, mesoporous Fe(3)O(4) nano/microspheres with large surface area for magnetic resonance imaging and therapeutic applications.
Xuan S; Wang F; Lai JM; Sham KW; Wang YX; Lee SF; Yu JC; Cheng CH; Leung KC
ACS Appl Mater Interfaces; 2011 Feb; 3(2):237-44. PubMed ID: 21229966
[TBL] [Abstract][Full Text] [Related]
14. Room-temperature preparation and characterization of poly (ethylene glycol)-coated silica nanoparticles for biomedical applications.
Xu H; Yan F; Monson EE; Kopelman R
J Biomed Mater Res A; 2003 Sep; 66(4):870-9. PubMed ID: 12926040
[TBL] [Abstract][Full Text] [Related]
15. One-pot preparation of fluorinated mesoporous silica nanoparticles for liquid marble formation and superhydrophobic surfaces.
Yildirim A; Budunoglu H; Daglar B; Deniz H; Bayindir M
ACS Appl Mater Interfaces; 2011 Jun; 3(6):1804-8. PubMed ID: 21574636
[TBL] [Abstract][Full Text] [Related]
16. Development of nanoaptamers using a mesoporous silica model labeled with (99m)tc for cancer targeting.
Sá LT; Pessoa C; Meira AS; da Silva MI; Missailidis S; Santos-Oliveira R
Oncology; 2012; 82(4):213-7. PubMed ID: 22508189
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica-magnetite nanocomposite synthesized by using a neutral surfactant.
Souza KC; Salazar-Alvarez G; Ardisson JD; Macedo WA; Sousa EM
Nanotechnology; 2008 May; 19(18):185603. PubMed ID: 21825691
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
[TBL] [Abstract][Full Text] [Related]
19. Uniform and size-tunable mesoporous silica with fibrous morphology for drug delivery.
Gai S; Yang P; Ma P; Wang L; Li C; Zhang M; Jun L
Dalton Trans; 2012 Apr; 41(15):4511-6. PubMed ID: 22373780
[TBL] [Abstract][Full Text] [Related]
20. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles.
Lu F; Wu SH; Hung Y; Mou CY
Small; 2009 Jun; 5(12):1408-13. PubMed ID: 19296554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
